JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
36mon MSN
Applications are being accepted for the MSc Drug Discovery Science program at the University of Sheffield. The start date is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback